News

Critical Pharmaceuticals, the speciality pharmaceuticals company, has won a translation award with the Wellcome Trust, which is valued at GBP1.5m, to develop a nasal spray of Human Growth

Affymetrix has entered into an agreement with Kaiser Permanente Research Program on Genes, Environment and Health (RPGEH) and the University of California at San Francisco (UCSF) to support

pSivida has reported that the last patient in the phase III clinical trial being conducted by its collaborative partner, Alimera Sciences (for a new treatment for diabetic macular

Dainippon Sumitomo Pharma (DSP) and Sepracor have completed the tender offer by DSP’s indirect wholly-owned subsidiary, Aptiom (Offeror), to acquire all outstanding shares of common stock of Sepracor

Fueled by strong sales of its rheumatoid arthritis drug Humira and nutritional products, Abbott Labs has reported net earnings of $1.48 billion for the third quarter of 2009,

Myriad Pharmaceuticals has identified an Investigational New Drug (IND) candidate targeting a novel molecular target, the protein kinase IKK epsilon. Reportedly, Myriad Pharmaceuticals’ IKK epsilon antagonist and IND

GlaxoSmithKline (GSK) and Prosensa, the Dutch-based biopharmaceutical company focusing on RNA modulating therapeutics, have entered into an exclusive worldwide collaboration for the development and commercialisation of RNA based

GEA Courtoy, a manufacturer of tabletting equipment for the pharmaceutical, food and chemical industries, has expanded its PERFORMA tablet press range with the PERFORMA S. The company has

Novartis has entered into an agreement for exclusive US and Canadian rights to Fanapt(iloperidone), a new oral medication that is approved by the US Food and Drug Administration